David S. Block

Biography

 David founded Gliknik in 2007 after 17 years in industry, 12 of which were in a series of commercial positions at DuPont Merck and DuPont Pharmaceuticals including sales management, licensing, R&D portfolio planning, market development, and product launch. He was the EVP of International Operations at the time of the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb. From 2002 to 2004, David was the Chief Operating Officer of Celera Genomics. Prior to founding Gliknik, he formed and ran a venture-backed CNS start-up. David received his M.D. and M.B.A. at the University of Pennsylvania and was board-certified in Internal Medicine before entering the biopharmaceutical industry.

Research Interest

 Autoimmune Disease and Cancer, Research and Development